Meiji Yasuda Asset Management Co Ltd. bought a new position in Danaher Corporation (NYSE:DHR – Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 4,115 shares of the conglomerate’s stock, valued at approximately $784,000.
Several other hedge funds and other institutional investors have also bought and sold shares of DHR. Main Street Group LTD bought a new stake in shares of Danaher in the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher during the 2nd quarter valued at $25,000. JPL Wealth Management LLC purchased a new position in Danaher in the 3rd quarter worth $25,000. WFA of San Diego LLC purchased a new position in Danaher in the 2nd quarter worth $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in Danaher in the fourth quarter worth $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
Shares of Danaher stock opened at $215.78 on Wednesday. The company’s fifty day simple moving average is $197.17 and its two-hundred day simple moving average is $192.36. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a market cap of $151.69 billion, a PE ratio of 38.33, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.
Analysts Set New Price Targets
DHR has been the subject of several analyst reports. TD Cowen cut their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Royal Bank Of Canada increased their target price on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Guggenheim reduced their price target on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Evercore reaffirmed an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $228.91.
View Our Latest Analysis on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
